Suppr超能文献

[强化诱导化疗能否根除1岁以上4期神经母细胞瘤患儿的腹膜后淋巴结转移?]

[Can intensive induction chemotherapy eradicate retroperitoneal lymph node metastases in children over 1 year of age with stage 4 neuroblastoma?].

作者信息

Niezgoda Aleksandra, Balwierz Walentyna, Bysiek Adam, Miezyński Witold, Klekawka Tomasz, Garus Katarzyna

机构信息

Klinika Onkologii i Hematologii Dzieciecej, Polsko-Amerykański Instytutu Pediatrii, Collegium Medicum, Uniwersytetu Jagiellońskiego w Krakowie.

出版信息

Przegl Lek. 2004;61 Suppl 2:9-13.

Abstract

The prognosis in patients over 1 year of age with stage 4 neuroblastoma (NBL) is poor in spite of intensive treatment. The choice of intensive chemotherapy and extension of the surgery, especially in the case when the tumor is localized in the abdomen, is still controversial. Between 1991-2001 there were 61 patients with NBL treated in our Department; 28 of them were older than 1 year and had stage 4 with the tumor localized in the abdomen. All children received intensive chemotherapy according to Japanese protocol. Three children with disease progression during intensive treatment where excluded from further analysis. In 22 children with good or very good response to chemotherapy, the surgery was performed. In 4 patients it was local surgery. In 18 patients the tumor was removed with all visible retroperitoneal lymph nodes (so called Tsuchida surgery). The histopathological evaluation was performed in 17 patients with Tsuchida surgery and in 13 cases metastases in retroperitoneal lymph nodes were found. The 5-year overall survival was significantly better in the group with Tsuchida surgery performed (0.66 vs 0.21, p=0.044) for the patients in stage 4. After the intensive induction of chemotherapy the metastases in retroperitoneal lymph nodes can still be found. The removal of the tumor with all retroperitoneal lymph nodes can improve treatment results in patients with advanced abdominal neuroblastoma, but it is necessary to investigate more patients and to prolong the observation period.

摘要

尽管进行了强化治疗,但1岁以上的4期神经母细胞瘤(NBL)患者预后仍较差。强化化疗方案的选择以及手术范围的扩大,尤其是当肿瘤位于腹部时,仍存在争议。1991年至2001年间,我科共治疗了61例NBL患者;其中28例年龄超过1岁,为4期,肿瘤位于腹部。所有患儿均按照日本方案接受了强化化疗。3例在强化治疗期间疾病进展的患儿被排除在进一步分析之外。22例对化疗反应良好或非常良好的患儿接受了手术。4例进行了局部手术。18例患儿的肿瘤连同所有可见的腹膜后淋巴结一并切除(即所谓的土田手术)。对17例行土田手术的患儿进行了组织病理学评估,其中13例发现腹膜后淋巴结转移。4期患者中,行土田手术组的5年总生存率明显更高(0.66对0.21,p = 0.044)。在强化诱导化疗后,仍可发现腹膜后淋巴结转移。切除肿瘤及所有腹膜后淋巴结可改善晚期腹部神经母细胞瘤患者的治疗效果,但有必要研究更多患者并延长观察期。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验